Haemonetics | HAE - سود ناخالص در فروش

قیمت سهام
58.58
تغییر روزانه
-0.32 -0.54%
ماهیانه
-4.42%
سالیانه
-8.47%
Q1 پیش بینی
58.11




سود ناخالص در فروش تغییر دادن تاریخ
Avanos Medical USD 86M 0 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Cerus USD 33.33M 8.66M 2024-12
Cooper Companies USD 695.2M 44.4M 2025-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Hologic USD 586.4M 2.9M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
Masimo USD 247.3M 16.7M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Neogen USD 106.7M 11.73M 2025-09
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD 274.8M 1.01B 2025-12
ResMed USD 878.72M 57.9M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 4.49B 633M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
US Physical Therapy USD 40.13M 3.26M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12